1. Home
  2. |Professionals
  3. |Jon O'Connell

Jon O'Connell

Partner
Partner
am9jb25uZWxsQGNyb3dlbGwuY29tIA==
VCardLinkedIn
VCardLinkedIn

Areas of Focus

Overview

Jon O'Connell is a co-lead of the Emerging Companies and Venture Capital practice, a partner in the Corporate Group and a resident in the firm's San Francisco office. He advises startup clients on matters related to corporate governance, venture capital financings, commercial transactions, and mergers and acquisitions. He also represents venture capital funds in equity financings.

Prior to joining the firm, Jon was an early employee and partner at a legal services and technology company providing startups with support to grow and scale their operations. He managed one of the most active venture capital financing teams in the industry having completed over 100 preferred stock equity financings. During his legal career at Am Law 100 firms, he has acted as outside general counsel for hundreds of startups in industries ranging from food tech to fintech.

Career & Education

|

    • University of California, Santa Barbara, B.A., 2008
    • Santa Clara University School of Law, J.D., 2011
    • University of California, Santa Barbara, B.A., 2008
    • Santa Clara University School of Law, J.D., 2011

    • California
    • California

Jon's Insights

Webinar | 02.25.25

First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era

Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.

View All Insights

Insights

Webinar | 02.25.25

First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era

Firm News | 1 min read | 01.27.25

Crowell Represents Iron Health in Acquisition by Metronomic

Firm News | 12.19.24

Crowell Represents Lumin Digital in $160 million Series A

Firm News | 1 min read | 11.22.24

Crowell & Moring Represents Anitian in Successful $7M Series D Funding
|

View All Insights

Practices

Industries

Jon's Insights

Webinar | 02.25.25

First 100 Days: Navigating New Frontiers: Life Sciences in the Trump Era

Please join us for a post-Election webinar with the heads of our Government Affairs group who will address the myriad of areas in the Life Sciences industry that will likely be impacted by the new administration, including FDA, NIH, drug pricing, imports, and exports.

View All Insights